Oaktree Acquisition Corp. II

Venture Capital

SPAC sponsored by Oaktree Capital Management that raised $250M in a Sept 2020 IPO and merged with Alvotech, an Icelandic biosimilars company, in a $2.28B deal announced Dec 2021.

Los Angeles, United States · 3+ investments

Late Stage
Public
Healthcare
Industrials
Life Sciences
Headquarters
Los Angeles, United States
Founded
2020
Total Investments
3
Last Investment
Dec 2021
Geographic Focus
Global, United States

Investment Thesis

Blank-check SPAC formed to acquire a high-quality growth business; completed merger with Alvotech (biosimilars) in 2022.

Oaktree Acquisition Corp. II is a Venture Capital firm based in Los Angeles, United States. It has made 3 investments in Healthcare and Industrials.

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Oaktree Acquisition Corp. II on Indexed.vc
<a href="https://indexed.vc/investors/oaktree-acquisition-corp-ii"><img src="https://indexed.vc/api/badge/investor/oaktree-acquisition-corp-ii" alt="Oaktree Acquisition Corp. II on Indexed.vc" width="260" height="76" /></a>